T-DXd
Other/Multi
Transition of average drug-to-antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography-tandem mass spectrometry
Habara H, Okamoto H, Nagai Y, et al.
Biopharm Drug Dispos. 2023;44(5):380-384.
Dato-DXd
Breast Cancer
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer
Dent RA, Cescon DW, Bachelot T, et al.
Future Oncol. 2023;19(35):2349-2359.
T-DXd
Gastric Cancer
Use of real-world evidence in a virtual bridging analysis for a human epidermal growth factor receptor 2-targeted antibody-drug conjugate in gastric cancer
Lu Z, Wada R, Salas M, et al.
J Clin Pharmacol. 2023;63(11):1244-1255.
T-DXd
Breast Cancer
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland
Paulissen JHJ, Seddik AH, Dunton KJ, et al.
Eur J Health Econ. 2024;25(4):689-699.
Edoxaban
Cardiovascular - AF
Relationship between direct oral anticoagulant doses and clinical outcomes in elderly patients with non-valvular atrial fibrillation — ANAFIE Registry sub-analysis
Akao M, Inoue H, Yamashita T, et al.
Circ J. 2023;87(12):1765-1774.
Edoxaban
Cardiovascular - AF
Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: Sub-analysis of ANAFIE registry, a large observational study
Terauchi Y, Inoue H, Yamashita T, et al.
Cardiovasc Diabetol. 2023;22:175.
T-DXd
Gastric Cancer
Trastuzumab deruxtecan dosing in human epidermal growth factor receptor 2-positive gastric cancer: population pharmacokinetic modeling and exposure-response analysis
Yoshihara K, Kobayashi Y, Endo S, et al.
J Clin Pharmacol. 2023;63(11):1232-1243.
Edoxaban
Cardiovascular - AF
Cardiovascular - VTE
Anticoagulant therapy and home blood pressure-associated risk for stroke/bleeding events in elderly patients with non-valvular atrial fibrillation: The sub-cohort study of ANAFIE registry
Kario K, Hasebe N, Okumura K, et al.
Hypertens Res. 2023;46:2572-2582.
Dato-DXd
Breast Cancer
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer
Bardia A, Jhaveri K, Kalinsky K, et al.
Future Oncol. 2024;20(8):423-436.
Edoxaban
Cardiovascular - AF
Causes of death in elderly patients with non-valvular atrial fibrillation - results from the ANAFIE registry
Yamashita T, Akao M, Atarashi H, et al.
Circ J. 2023;87(7):957-963.
